Lates News

The Food and Drug Administration (FDA) has approved Gilead's antiviral medication for preventing HIV twice a year. The company and some experts say that this is a milestone that could help the world get closer to ending the decades-long HIV epidemic. However, the launch of the injectable drug lenacapavir faces a series of potential threats, including the Trump administration's proposal to cut federal funding for HIV prevention efforts.